Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for HCAT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 0.275M
March 31, 2026 18.51M
December 31, 2025 9.912M
September 30, 2025 -0.464M
June 30, 2025 -8.997M
March 31, 2025 0.28M
December 31, 2024 -3.527M
September 30, 2024 6.208M
June 30, 2024 1.612M
March 31, 2024 10.27M
December 31, 2023 -19.04M
September 30, 2023 3.115M
June 30, 2023 -11.57M
March 31, 2023 -5.58M
December 31, 2022 -14.82M
September 30, 2022 -12.03M
June 30, 2022 -9.576M
Date Value
March 31, 2022 1.158M
December 31, 2021 -9.775M
September 30, 2021 -5.36M
June 30, 2021 -4.845M
March 31, 2021 -3.143M
December 31, 2020 -4.141M
September 30, 2020 -4.487M
June 30, 2020 -0.751M
March 31, 2020 -16.77M
December 31, 2019 -13.06M
September 30, 2019 -5.482M
June 30, 2019 -8.417M
March 31, 2019 -5.224M
December 31, 2018
September 30, 2018
June 30, 2018
March 31, 2018 -7.387M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
LataMed AI Corp. -0.055M
SCWorx Corp. -0.0057M
GoodRx Holdings, Inc. 80.83M
Claritev Corp. 92.67M
iSpecimen, Inc. -0.6896M